- Home
- FNGR vs HOWL Comparison
FNGR vs HOWL Comparison
Compare FNGR & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNGR
- HOWL
- Stock Information
- Founded
- FNGR 2016
- HOWL 2017
- Country
- FNGR Singapore
- HOWL United States
- Employees
- FNGR N/A
- HOWL N/A
- Industry
- FNGR Computer Software: Prepackaged Software
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- FNGR Technology
- HOWL Health Care
- Exchange
- FNGR Nasdaq
- HOWL Nasdaq
- Market Cap
- FNGR 108.1M
- HOWL 87.4M
- IPO Year
- FNGR N/A
- HOWL 2021
- Fundamental
- Price
- FNGR $2.08
- HOWL $1.64
- Analyst Decision
- FNGR
- HOWL Strong Buy
- Analyst Count
- FNGR 0
- HOWL 2
- Target Price
- FNGR N/A
- HOWL $13.50
- AVG Volume (30 Days)
- FNGR 205.1K
- HOWL 411.3K
- Earning Date
- FNGR 01-14-2025
- HOWL 11-07-2024
- Dividend Yield
- FNGR N/A
- HOWL N/A
- EPS Growth
- FNGR N/A
- HOWL N/A
- EPS
- FNGR N/A
- HOWL N/A
- Revenue
- FNGR $31,176,174.00
- HOWL $3,386,000.00
- Revenue This Year
- FNGR $260.03
- HOWL N/A
- Revenue Next Year
- FNGR N/A
- HOWL $34.17
- P/E Ratio
- FNGR N/A
- HOWL N/A
- Revenue Growth
- FNGR N/A
- HOWL N/A
- 52 Week Low
- FNGR $1.63
- HOWL $1.58
- 52 Week High
- FNGR $4.36
- HOWL $8.19
- Technical
- Relative Strength Index (RSI)
- FNGR 52.93
- HOWL 35.21
- Support Level
- FNGR $1.95
- HOWL $1.62
- Resistance Level
- FNGR $2.70
- HOWL $1.72
- Average True Range (ATR)
- FNGR 0.12
- HOWL 0.13
- MACD
- FNGR 0.02
- HOWL -0.01
- Stochastic Oscillator
- FNGR 22.50
- HOWL 6.38
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.